期刊文献+

无痛分娩临床应用中的伦理困境及应对措施

Ethical Dilemmas and Corresponding Measures in the Clinical Application of Painless Delivery
下载PDF
导出
摘要 随着我国推出全面放开生育新政策,越来越多的产妇将会面临分娩之痛。虽然无痛分娩技术已经有百年的历史,但是在我国整体的普及率还远远低于欧美国家,在临床使用过程中仍然面临着严峻的问题,包括知情同意落实不规范、价值观和认知度的不足、麻醉医师的缺乏与舒适分娩需求之间的矛盾、医保支付政策不完善以及用药风险等伦理问题。因此,为了有效规避伦理风险,规范无痛分娩的临床应用。提出应该保障产妇的健康权和生命权、规范知情同意、完善医保支付政策、完善相关法律制度、加强人文关怀合理推广无痛分娩。 With the introduction of new policies in China that comprehensively lift birth restrictions,an increasing number of expectant mothers will face the pain of childbirth.Although labor analgesia technology has a century of history,the overall popularity rate in China is still far lower than that of European and American countries.In the clinical application process,it still faces severe challenges,including non-standard implementation of informed consent,insufficient values and awareness,conflicts between the shortage of anesthesiologists and the demand for comfortable delivery,imperfect medical insurance payment policies,and ethical issues such as medication risks.Therefore,in order to effectively avoid ethical risks and standardize the clinical application of painless delivery,it is proposed to safeguard the health and life rights of puerpera,standardize informed consent,improve medical insurance payment policies,improve relevant legal systems,strengthen humanistic care,and promote painless childbirth in a reasonable manner.
作者 邓祥 伊静 马文兵 DENG Xiang;YI Jing;MA Wen-bing(Department of Pharmacology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China)
出处 《医学与哲学》 北大核心 2023年第18期20-24,共5页 Medicine and Philosophy
基金 2021年陕西省自然科学基金一般项目(2021SF-130)。
关键词 无痛分娩 知情同意 伦理问题 生育权 painless delivery informed consent ethical issue reproductive rights
  • 相关文献

参考文献4

二级参考文献12

  • 1孟冬祥,尹常宝,陈雪华,董兴栋,郭惠明,贾乃光.不同人群对无痛分娩的认知及其临床应用影响因素的调查[J].中国疼痛医学杂志,2005,11(3):150-153. 被引量:20
  • 2[1]Zhanf J, Yancey MK, Henderson CE. US National trends in labor induction,1989-1998. J Reprod Med ,2002,47:120-124.
  • 3[2]Bishop EM. Pelvic scoting for elective induction. Obstet Gynecol, 1964,24:266-268.
  • 4[3]Stitely ML and Statin AJ. Cervical ripening agents and uterine stimulants. Clin Obstet Gynecol, 2002,45(1):114-124.
  • 5[4]Blair FC, Tassone SA, Pearman CR et al. Initiation of labor using a sustained-release PGE2 vaginal insert.Experience at a community hospital. J Reprod Med,1997,43:408-412.
  • 6[5]Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev,2001,(2):CD003101.
  • 7[6]Hadi HA. Cervical ripening and labor induction: clinical guidelines. Clin Obstet Gynecol, 2000,43:524-536.
  • 8[7]Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labor. Cochrone Database Syst Rev, 2003,(1):CD00941.
  • 9[8]American College of Obstetricians and Gynecologists. Response to Searle's drug warning on misoprostol. ACOG committee opinion no.248. Washington. DC: American College of Obstetricians and Gynecologists, 2000,159.
  • 10[9]Sanchez-Ramos L, Kaunitz AM, Delke L. Labor induction with 25μg versus 50 μg Intravaginal misoprostol: A systematic review. Obstet Gynecol, 2002,99:145-151.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部